Sonoma Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of SNOA for the last quarter is 3.14 M USD, and it's 14.90% higher compared to the previous quarter. The net income of Q3 23 is -866.00 k USD.